RUNX2 also inhibited the proliferation of osteogenic potential cells and osteosarcoma cells, and transfection of siRNA against RUNX2 into human mesenchymal stem cells increased their proliferation [41]. The gene discussed is RUNX2; the disease is osteosarcoma.